Clinical Trial Update: A Study of Pegasys (Peginterferon Alfa-2a) Added to Nucleos(t)Ide Analogue Treatment in Participants With HBeAg-Negative Chronic Hepatitis B Genotype D Showing Stable Hepatitis B Virus (HBV) Deoxyribonucleic Acid (DNA) Suppression [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the addition of Pegasys (peginterferon alfa-2a) to nucleos(t)ide analogue therapy in adults with HBeAg-negative chronic hepatitis B gen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis B, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2016-08-05